Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179829 · ClinicalTrials.gov registry record · Phase 2
WT1 for the Detection of Minimal Residual Disease
A Phase 2 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00179829 is a Phase 2 study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 50 participants.
The verdict
NCT00179829, a Phase 2 study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if WT1 is an adequate measurement of minimal residual disease in leukemic patients.
Interventions
- PROCEDURE WT 1 Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 1999-02 |
| Est. Completion | 2006-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179829
The ClinicalTrials.gov registry entry for NCT00179829 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which WT 1 Testing is the first listed.
NCT00179829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179829 about?
NCT00179829 is a clinical study titled "WT1 for the Detection of Minimal Residual Disease". The purpose of this study is to determine if WT1 is an adequate measurement of minimal residual disease in leukemic patients.
What is the current status of trial NCT00179829?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 1999-02. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00179829?
The interventions under investigation include: WT 1 Testing (PROCEDURE).
Who is sponsoring clinical trial NCT00179829?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.